Comparison of clinical outcomes between direct and indirect transfer in patients with ST-segment elevation myocardial

Yoshiaki Hai1, Kenichi Sakakura2, Hiroyuki Jinnouchi1

  • 1Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University, 1-847 Amanuma, Omiya, Saitama City, 330-8503, Japan.

Insights

Direct ambulance transport to a primary percutaneous coronary intervention (PCI) facility for ST-segment elevation myocardial infarction (STEMI) is not superior to indirect transfer for major adverse cardiovascular events (MACE) in patients with a choice.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Public Health

Background:

  • Primary percutaneous coronary intervention (PCI) is the standard treatment for ST-segment elevation myocardial infarction (STEMI).
  • Prior research suggested direct ambulance transport to PCI facilities improves outcomes, but often included critically ill patients.
  • The optimal transport strategy for STEMI patients with transport choices remains unclear.

Purpose of the Study:

  • To compare clinical outcomes between direct ambulance transport and indirect transfer (via primary care physician) in STEMI patients who had a choice.
  • To determine if indirect transfer is associated with increased major adverse cardiovascular events (MACE).

Main Methods:

  • A cohort study of 462 STEMI patients who could choose between direct or indirect transport.
  • Primary endpoint: Major Adverse Cardiovascular Events (MACE), a composite of death, non-fatal MI, heart failure re-admission, and target vessel revascularization.
  • Follow-up duration: Median 540 days. Statistical analysis adjusted for confounders.

Main Results:

  • Direct transport group had a significantly shorter onset-to-balloon time.
  • No significant difference in MACE rates between direct (31.4%) and indirect (27.2%) transfer groups (p=0.330).
  • Indirect transfer was not associated with MACE after adjusting for confounders (aHR=0.740, p=0.161).

Conclusions:

  • For STEMI patients with the option to choose, indirect transfer via primary care physician is not associated with worse clinical outcomes compared to direct ambulance transport.
  • These findings challenge the universal recommendation for direct transport when patient choice is possible.

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...